HOME >> BIOLOGY >> NEWS
Huntington's cure in flies lays groundwork for broader treatment approaches

MADISON-Boosting levels of two critical proteins that normally shut down during Huntington's disease, researchers at the University of Wisconsin-Madison and the Cold Spring Harbor Laboratory have cured fruit flies of the genetic, neurodegenerative condition.

Forms of the same proteins-known in short form as CREB and HSP-70--exist in all cells, including those of humans.

The study results, published online today by the Proceedings of the National Academy of Sciences, were a "logical finding" because of a growing body of work in the area, says senior author Jerry Yin, a UW-Madison molecular geneticist. Scientists previously knew, for example, that hiking the activity of either CREB or HSP-70 lessened symptoms in mice or flies with Huntington's disease.

Completely reversing a disease by targeting a combination of proteins or genetic pathways, however, reflects the growing need to embrace a broader treatment paradigm in the realm of genetic disorders, says Yin.

In working with a disorder such as Fragile X Syndrome, for example, conventional therapies might focus all their efforts on repairing the genetic pathways that cause neurons to go awry. Meanwhile, "the defective gene is not just in one type of tissue," says Yin. "And we are not yet sensitive to detecting the defects in those other tissues."

Rather than focusing treatment strategies on single genetic pathways, then, Yin believes a promising alternative might be to simultaneously target a cocktail of gene-induced activities - all of which are set in motion, for example, by a single faulty gene.

Yin has long worked in the area of "triplet expansion" diseases such as Huntington's and Fragile X, in which genes go haywire due to a coding defect. His collaborators on the recent fruit fly work include, among others, lead author Kanae Iijima-Ando of the Cold Spring Harbor Laboratory and UW-Madison assistant scientist Eric Drier.

Working with the simplistic genetics
'"/>

Contact: Jerry Yin
jcyin@wisc.edu
608-262-5014
University of Wisconsin-Madison
11-Jul-2005


Page: 1 2

Related biology news :

1. Huntingtons disease study shows animal models on target
2. Drug protects brain cells in Huntingtons disease model, researchers find
3. Better sleep may put Huntingtons disease sufferers back on track
4. Subtle signs can help predict Huntingtons disease early
5. Landmark study identifies large number of new proteins implicated in Huntingtons disease
6. Study links faulty DNA repair to Huntingtons disease onset
7. Proteasome activator enhances survival of Huntingtons disease neuronal model cells
8. Test reveals effectiveness of potential Huntingtons disease drugs
9. Metabolic disorder underlies Huntingtons disease
10. Unique Huntingtons study moves forward
11. Gene therapy injected into the brains of mice with Huntingtons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2020)... ... May 06, 2020 , ... ... ) will become the latest out-of-state company to partner with the device ... Brevitest has developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent ...
(Date:4/30/2020)... LOS ALAMOS, N.M. (PRWEB) , ... April 28, 2020 , ... ... some of the world’s biggest challenges in agriculture and aquaculture with the mission of ... eight presenters at the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ...
(Date:4/26/2020)... ... April 23, 2020 , ... A team of researchers at the Icahn School ... to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to ... option for COVID-19. , The efforts are being led by Mone Zaidi, MD, PhD, ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... , ... May 21, 2020 , ... ... clinical trials will cause long-term harm , Contrary to conventional wisdom that says ... study finds many companies will emerge from the pandemic commercially weaker, dealing ...
(Date:5/21/2020)... , ... May 20, 2020 , ... ... of Simon Prakash, who will serve as the company’s executive vice president of ... time when Exo is disrupting the medical imaging space, bringing more than 24 ...
(Date:5/15/2020)... ... , ... This new service offers clients a way to speak with Subject ... the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of ... OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am – ...
(Date:5/14/2020)... , ... May 12, 2020 , ... ... for translational research, is bringing together thousands of industry leaders, clinicians, research scientists, ... highlights two plenary speakers, Carl June, MD, Director of the Center for Cellular ...
Breaking Biology Technology:
Cached News: